Abstract
Lysine demethylases play an important role in epigenetic regulation and thus in the development of diseases like cancer or neurodegenerative disorders. As the lysine specific demethylase 1 (LSD1/KDM1) has been strongly connected to androgen and estrogen dependent gene expression, it serves as a promising target for the therapy of hormone dependent cancer. Here, we report on the discovery of new small molecule inhibitors of LSD1 containing a propargylamine warhead, starting out from lysine containing substrate analogues. On the basis of these substrate mimicking inhibitors, we were able to increase potency by a combination of similarity-based virtual screening and subsequent synthetic optimization resulting in more druglike LSD1 inhibitors that led to histone hypermethylation in breast cancer cells.
Original language | English (US) |
---|---|
Pages (from-to) | 7334-7342 |
Number of pages | 9 |
Journal | Journal of Medicinal Chemistry |
Volume | 56 |
Issue number | 18 |
DOIs | |
State | Published - Sep 26 2013 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery